MedTrace Logo

Outcomes of Bilateral Implantation of an Enhanced Monofocal Intraocular Lens

NCT06118944 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2023-11-07

No results posted yet for this study

Summary

To evaluate and compare the visual outcomes of an enhanced monofocal intraocular lens (IOL) with two different monofocal IOLs in patients scheduled for bilateral cataract surgery.

Conditions

  • Cataract

Interventions

DEVICE

ICB00 IOL

Bilateral implantation of ICB00 IOL

DEVICE

ZCB00 IOL

Bilateral implantation of ZCB00 IOL

DEVICE

CNA0T0 IOL

Bilateral implantation of CNA0T0 IOL

Sponsors & Collaborators

  • University of Trieste

    lead OTHER

Principal Investigators

  • Daniele Tognetto, MD · University of Trieste

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-11
Primary Completion
2022-09-30
Completion
2023-01-31
FDA Device
Yes

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06118944 on ClinicalTrials.gov